Human PlGF-1 Recombinant Protein, PeproTech

The University of Virginia issued purchase order A207_PO-0466779 to Life Technologies Corporation on August 7, 2026, for the procurement of specialized biological materials. The contract encompasses the delivery of Human Placental Growth Factor-1 Recombinant Protein manufactured by PeproTech, with a total contract value of $220.50. The material is designated for delivery to Dulani Dinishi Senarathne, and the procurement consists of a single unit of the specified recombinant protein product.

As a Virginia-based state and local contract award, this purchase order represents a routine procurement of research-grade biological reagents by a major state educational institution. The relatively modest contract value and singular line item indicate this is a targeted acquisition to support ongoing research or laboratory operations at the University of Virginia. No specific performance period or annual value breakdown is documented in the award record, suggesting this represents a discrete purchase transaction rather than a multi-year service agreement.